Tampa General Hospital (TGH) Cancer Institute has promoted Dr. David Swoboda to the position of Clinical Director of Leukemia. In his new role, Dr. Swoboda will oversee the growth of a highly specialized team of physicians, advanced practice providers (APPs), pharmacists, nurse navigators and other supportive-care providers, focusing on the treatment of patients with acute leukemias and myelodysplastic syndromes (MDS), conditions that can occur when the blood-forming cells in the bone marrow become abnormal. Dr. Swoboda joined the Cancer Institute in 2021.
Prior to joining Tampa General, he was a chief hematology-oncology fellow at Moffitt Cancer Center in Tampa after having served as a chief resident at MedStar Georgetown University Hospital in Washington, DC. Dr. Swoboda received his medical degree from Florida State University College of Medicine in Tallahassee, where he was the president of the Internal Medicine Interest Group. He is a member of the American Society of Hematology, Society for Hematology Oncology, American Society of Clinical Oncology, and American College of Physicians.
